Home parenteral nutrition for advanced cancer patients: Contributes to survival?

Miriam Theilla, Johnathan Cohen, Ilya Kagan, Joelle Attal-Singer, Shaul Lev, Pierre Singer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objectives: Patients with advanced cancer often suffer from severe malnutrition and gastrointestinal obstruction. This population could benefit from home parenteral nutrition (HPN). The aim of this study was to observe the outcome of patients with advanced cancer patients who were eligible for HPN. Methods: All patients in the nutrition clinic who received HPN over the past 7 y were included in the present study. We compared patients with advanced cancer with the noncancer population in terms of hospitalization rate and mortality. Results: Of 221 advanced cancer patients, 153 who had no oral/enteral intake and who received HPN survived. Of these, 35% survived for 6 mo, 27% for 1 y, 18.9% survived 2 y, and 3.9% survived for the 7 y of the follow-up. Hospitalization rate was not significantly different from the noncancer population. Conclusion: These results show that HPN is a relevant palliative therapy for patients with advanced cancer patients without oral or enteral feeding access.

Original languageEnglish
Pages (from-to)197-200
Number of pages4
StatePublished - Oct 2018


  • Advanced cancer
  • Gastrointestinal obstruction
  • Home parenteral nutrition
  • Karnofsky scale score
  • Palliative care


Dive into the research topics of 'Home parenteral nutrition for advanced cancer patients: Contributes to survival?'. Together they form a unique fingerprint.

Cite this